MedPAC Eyes Axing ESRD Drug Add-On Pay As Trump Touts Kidney Care
Some kidney care stakeholders say the Medicare Payment Advisory Commission seems to be at odds with the administration over the need for innovation in treatments for end stage renal disease patients after commissioners at their January meeting leaned toward eliminating the transitional drug add-on payment adjustment to the ESRD pay bundle. But the payment advisors…
John P. Butler, President and CEO of Akebia Therapeutics, Takes Helm as New Chair of Nation’s Largest Kidney Coalition
Butler will focus on supporting innovation to improve patient-centric care for individuals living with kidney disease, kidney failure and transplants Washington, DC—Kidney Care Partners (KCP) – the nation’s leading kidney care coalition composed of patients, caregivers, providers, researchers and manufacturers – is pleased to announce John P. Butler as its new chair. Butler, a long-standing…
Patients need cohesive health care coverage to cope with kidney disease
From the perspective of policy makers, patient advocates and health care providers, chronic kidney disease and kidney failure present the following series of important questions: How do we, as a nation, tackle the economic and physical implications of a health care epidemic that when undiagnosed or left untreated, results in loss of vital organ function…